Rothblatt Martine A's Form 4 filing
United Therapeutics Corp (UTHR) · filed Sep 16, 2026
- Accession no.
- 0001106578-26-000142
- Filed
- Sep 16, 2026, 4:35 PM ET
- Trade date
- Sep 15, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 7 non-derivative transactions and 1 derivative transaction. Open-market sales total $4.77M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rothblatt Martine ACIK 0001106578 | Director, Officer (Chairperson & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | Common Stock | MOption exerciseAcquired | +9,500 | $117.76 | +$1,118,720 | 333,943 | Indirect | |
| Sep 15, 2026 | Common Stock | SSaleDisposed | −780 | $499.77F3 | −$389,823.88 | 333,163 | Indirect | |
| Sep 15, 2026 | Common Stock | SSaleDisposed | −3,711 | $500.68F4 | −$1,858,019.4 | 329,452 | Indirect | |
| Sep 15, 2026 | Common Stock | SSaleDisposed | −2,689 | $501.66F5 | −$1,348,969.92 | 326,763 | Indirect | |
| Sep 15, 2026 | Common Stock | SSaleDisposed | −825 | $502.57F6 | −$414,620.33 | 325,938 | Indirect | |
| Sep 15, 2026 | Common Stock | SSaleDisposed | −845 | $503.80F7 | −$425,714.8 | 325,093 | Indirect | |
| Sep 15, 2026 | Common Stock | SSaleDisposed | −650 | $504.57F8 | −$327,970.96 | 324,443 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | Common Stock | MOption exerciseDisposed | −9,500 | $0.00 | $0 | 432,910 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
This transaction was executed in multiple trades at prices ranging from $499.24 to $500.23. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $500.25 to $501.22. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $501.25 to $502.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $502.26 to $503.25. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $503.27 to $504.26. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F8
This transaction was executed in multiple trades at prices ranging from $504.27 to $505.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.